D.E. Shaw & Co
RPTP

D.E. Shaw & Co’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

D.E. Shaw & Co’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-931,488
Closed -$8.36M – 3798
2016
Q3 		$8.36M Sell
931,488
-1,019,667
-52% -$7.25M 0.01% 995
2016
Q2 		$10.5M Buy
1,951,155
+94,888
+5% +$486K 0.02% 869
2016
Q1 		$8.54M Sell
1,856,267
-496,356
-21% -$2M 0.02% 947
2015
Q4 		$12.2M Sell
2,352,623
-199,157
-8% -$1.16M 0.02% 882
2015
Q3 		$15.4M Buy
2,551,780
+322,619
+14% +$3.95M 0.02% 729
2015
Q2 		$35.2M Buy
2,229,161
+1,339,131
+150% +$16.3M 0.05% 426
2015
Q1 		$9.68M Buy
890,030
+477,468
+116% +$4.87M 0.01% 981
2014
Q4 		$4.34M Buy
412,562
+44,357
+12% +$433K 0.01% 1682
2014
Q3 		$3.53M Sell
368,205
-64,487
-15% -$659K ﹤0.01% 1803
2014
Q2 		$5M Buy
432,692
+204,422
+90% +$1.86M 0.01% 1631
2014
Q1 		$2.28M Sell
228,270
-80,035
-26% -$1.16M ﹤0.01% 2254
2013
Q4 		$4.01M Sell
308,305
-2,255
-0.7% -$31.1K 0.01% 1886
2013
Q3 		$4.64M Buy
+310,560
New +$3.72M 0.01% 1667

D.E. Shaw & Co's RPTP Position: Q4 2016 in Review

D.E. Shaw & Co sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 931,488 shares — an estimated $8.36M sold.

D.E. Shaw & Co first reported a position in RPTP in Q3 2013 and held it in 13 quarters. The position peaked at $35.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • D.E. Shaw & Co reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 931,488 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $8.36M.
  • D.E. Shaw & Co first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 13 quarters.
  • D.E. Shaw & Co's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $35.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.